The FDA-approved drug Pluvicto offers hope for advanced prostate cancer patients, but access barriers remain despite proven ...

Movember is back. Throughout the month of November, men are skipping their razors in favour of sporting a moustache to help ...

If critics of drug makers had their way, the ‘Dilbert’ creator wouldn’t have a chance against his prostate cancer.

Poorer health is linked to votes for Reform UK People with poorer health are more likely to vote for the populist right wing political party Reform UK, showed a study published in BMJ Open Respiratory ...

The Prostate Cancer Foundation of New Zealand (PCFNZ) is hitting the road this November, with a six-centre programme aimed at helping men living with advanced prostate cancer, and their families, ...

President Donald Trump said he is 'on it' after 'Dilbert' creator Scott Adams asked for help with prostate cancer treatment.

R&B icon Montell Jordan raises awareness for men's health, emphasizing the importance of early detection in the fight against ...

A 75-year-old man, Mr. A, had prostate cancer that had metastasized to his pelvis and spine. Despite attempts with multiple ...

GSK plc ( NYSE: GSK) and Syndivia on Monday announced an agreement granting GSK exclusive worldwide rights to develop and ...

The combination of niraparib and abiraterone halves the spread of prostate cancer in men with BRCA gene mutations.

A powerful new drug combo has yielded a major breakthrough for men battling an aggressive form of prostate cancer, researchers found in a clinical trial.

Men whose prostate cancer returns after surgery or radiation therapy may now benefit from a new drug combination shown in ...